90.9 WBUR - Boston's NPR news station
Top Stories:
PLEDGE NOW
Here and Now with Robin Young
Public radio's live
midday news program
With sponsorship from
Mathworks - Accelerating the pace of engineering and science
Accelerating the pace
of engineering and science
Wednesday, October 10, 2012

Fungal Meningitis Outbreak Renews Scrutiny Of Pharmacy Rules, Regulators

A pharmacist mixes medication at a compounding pharmacy in West Palm Beach, Fla. Thousands of these pharmacies operate nationwide. A compounding pharmacy in Massachusetts has been blamed for a deadly outbreak of fungal hepatitis. (AP/Brian Skoloff)

Congressional committee leaders are asking health officials for briefings on the fungal meningitis outbreakthat has now killed 12 people in 10 states. In Tennessee, where six patients given contaminated steroid injections for back pain have died, Gov. Bill Haslam says the state will not rush to implement new rules.

A vial of injectable steroids from the New England Compounding Center is displayed in the Tennessee Department of Health in Nashville. (AP/Kristin M. Hall)

But The Tennessean reports that California is already taking steps to tighten standards, even though no deaths have been reported there, and California already has some of the nation’s strictest rules for compounding pharmacies.

Questions are also being asked about regulators themselves. The Boston Globe reports that owners of the New England Compounding Center, implicated in the outbreak, also own another pharmacy and one of the executives there is a board member of the state agency that regulates pharmacies.

Dr. Sarah Sellers, a licensed pharmacist who has been working in compounding pharmacies and testified before Congress in 2003 about her concerns about them, tells Here & Now‘s Robin Young that physicians and patients are not aware of the risks of products made at compounding pharmacies and, in her opinion, “we are only beginning to scratch the surface” of deaths and other health complications caused by drugs made there.

In an opinion piece published in the journal Drugs, she argues that there is not enough mandatory reporting of problems associated with compounding pharmacies.

Guest:

  • Dr. Sarah Sellers, pharmacist and former FDA compliance regulator

Please follow our community rules when engaging in comment discussion on this site.
  • http://twitter.com/mem_somerville mem_somerville

    I am saddened by this incident. But I’m kinda glad this is getting some scrutiny. I think this could become more and more important in medicine, actually. We are going to start getting more personalized cocktails of compounds to treat individuals as we learn more about their genomes. And we will get more unusual combos with cancer treatment cocktails as we get tumor sequence data too.

    This is a service we’ll need, but it does need to be regulated properly. 

Robin and Jeremy

Robin Young and Jeremy Hobson host Here & Now, a live two-hour production of NPR and WBUR Boston.

April 22 Comment

What Do We Have To Teach Plato?

Philosopher Rebecca Newberger Goldstein discusses her new book "Plato at the Googleplex: Why Philosophy Won't Go Away."

April 22 21 Comments

Children’s Literature: Apartheid Or Just A General Lack of Color?

African-American children's book authors Walter Dean Myers and his son Christopher Myers weigh in.

April 21 Comment

Remembering Rubin ‘Hurricane’ Carter

We remember the boxing champion, who was twice wrongly convicted of murder, with his longtime friend and defender.

April 21 2 Comments

‘Wait Wait’ Host Peter Sagal Runs Boston Marathon As Guide

For the second year in a row, the host of NPR's "Wait Wait... Don't Tell Me" is running with a legally blind athlete.